Annual Conference

2013 Boston Bioforum: the Fifth CABA Annual Conference

By Hao Li, Executive Committee, CABA

On the beautiful spring Saturday of April 27, by the riverbank of Charles River with bright morning sunshine, blue sky and white sails, over 300 company executives, senior scientists, entrepreneurs and investors from the biopharmaceutical industry gathered at MIT faculty club for the 2013 Boston BioForum “Accelerating Drug Development, from Bench to Bedside”,

Boston BioForum – 2015 CABA Annual Conference "Shaping the Biomedical Industry through Collaborative Innovation"

The theme of the conference: Shaping the Biomedical Industry through Collaborative Innovation The conference will focus on the following topics: 1) Emerging technologies for future therapeutics: Gene therapy, Precision medicine, etc.; 2) Rare disease; 3) Clinical development; 4) Innovation in pharma business models. Human resources and seasoned professionals from local and Chinese biotech companies will also join our career development panel discussions and onsite interviews. The annual conference is the most influential event among all the activities CABA organizes each year, which include symposia, seminars and workshops on drug discovery, development, marketing, licensing, IP issues, regulatory compliance in both the U.S. and China, and many cultural and networking gatherings. Last year’s CABA annual conference attracted over 300 participants including renowned biopharmaceutical company executives, scientists, entrepreneurs and academic professors. If you have any question, please contact Dr. Shi by email or phone. Xiangguo (Eric) Shi, Ph.D., Conference Chair Email: eric.xg.shi@gmail.com Tel: (781) 975-2378 To register for the conference, please clink here.

Pages